The Tincan Island Command of the Nigeria Customs Service reported the interception of 16 containers filled with illicit substances, unregistered pharmaceutical products, and various other items. These containers were discharged between May 17 and October 23, 2024, and have a duty-paid value of N4bn.
During a press briefing in Apapa, Lagos, on Thursday, Customs Area Controller Dera Nnadi announced that the command had collected a remarkable N1.046tn in revenue from January to November 7, 2024. This achievement marks the first time the command has reached such a significant revenue milestone.
Nnadi emphasized that this success in revenue generation was made possible through the cooperation of various stakeholders involved in the process. He expressed satisfaction with the command’s performance, stating, “We are glad to announce that as of today, November 7, 2024, we have generated the sum of N1.046tn.”
In addition to the revenue report, Nnadi mentioned that 13 containers containing illicit drugs would be transferred to the officers of the National Agency for Foods and Drug Administration and Control. This handover is part of the command’s ongoing efforts to tackle drug-related issues in the region.
Read Also: AI Tools for Parenting are Coming, and A16z is Ready to Support Them.
He elaborated that these containers underwent inspections by multiple agencies, including the Nigeria Customs Service and the National Drug Law Enforcement Agency, among others. This collaborative approach aims to ensure thorough scrutiny of shipments entering the country.
Providing further details on the seizures, Nnadi explained that several containers were found carrying large quantities of cough syrups containing codeine, barcadin, broncleer, and DSP, all intended for treating throat and chesty coughs. These products were packaged in 100ml and 200ml bottles per carton.
The command’s proactive measures and successful revenue collection highlight its commitment to combating illegal activities and enhancing regulatory compliance within the pharmaceutical sector.
